Stallion India Fluorochemicals : Aggressive Capex
Read original sourceAI Analysis
The specialty chemicals sector, particularly fluorochemicals, is witnessing significant growth driven by diverse industrial applications and import substitution initiatives. Increased domestic manufacturing of key components like R-32 aligns with India's 'Make in India' push.
Trading Insight
Key Evidence
- •Stallion India Fluorochemicals is moving into backward integration by manufacturing R-32.
- •The company's current focus is on formulation, blending, debulking, and distribution of fluorochemicals.
- •The backward integration aims to cut down on imports and boost margins.
- •Stallion's products serve diverse industries including automotive, pharmaceuticals, fire safety, defence, power, solar, and semiconductors.
- •Key OEM customers include BlueStar, Voltas, Daikin, LG, and Amber.
Affected Stocks
Aggressive capex for backward integration into R-32 manufacturing, aiming to cut imports and boost margins, indicating future growth potential.
As an OEM customer, increased domestic production of R-32 could lead to more stable supply chains and potentially better pricing.
As an OEM customer, increased domestic production of R-32 could lead to more stable supply chains and potentially better pricing.
As an OEM customer, increased domestic production of R-32 could lead to more stable supply chains and potentially better pricing.
AI-powered analysis by
Anadi Algo News